Information  X 
Enter a valid email address

Vectura Group plc (VEC)

  Print      Mail a friend

Monday 01 April, 2019

Vectura Group plc

BLOCK LISTING RETURN

RNS Number : 6698U
Vectura Group plc
01 April 2019
 

 

Vectura Group plc

BLOCK LISTING RETURN

 

Date:  1 April 2019

Name of applicant: Vectura Group plc

Block Listing Return for the period 1 December 2018 to 31 March 2019

Name of scheme (s)

Vectura Group plc Sharesave Scheme 

Vectura Group plc Long Term Incentive Plan 

Vectura Group plc  Unapproved Share Option Plan

Vectura Group plc  Approved Share Option Plan

*Innovata Option Scheme

Vectura Share Incentive Plan

Total

Balance of unallotted securities under scheme(s) at the beginning of the period

651,856

556,819

43,826

444,681

1,006,128

155,771

2,859,081

Plus: The amount by which block scheme(s)  have been increased during the period

-

2,500,000

500,000

-

-

2,000,000

5,000,000

Less: Number of securities issued/allotted under scheme(s) during the period

(105,143)

(1,792,552)

(492,439)

(315,068)

-

(1,274,288)

(3,979,490)

Equals: Balance under scheme(s) not yet issued/allotted at the end of the period

546,713

1,264,267

51,387

129,613

1,006,128

881,483

3,879,591

Total number of securities in issue at the end of the period (0.025p ordinary shares)

-

-

-

-

-

-

655,387,145

 

*Please note that the block listing for the above scheme is no longer required as the scheme has expired and there are no outstanding options. Accordingly, the remaining block listed shares will not be utilised.

Enquiries:                  

Vectura Group plc

+44 (0)20 7881 0524



John Murphy

Company Secretary








Consilium Strategic Communications

+44 (0)20 3709 5700



Mary-Jane Elliott / Susan Stuart/ Jessica Hodgson


 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
BLRUGUAWCUPBUBG

a d v e r t i s e m e n t